Analysis of DLL3 and ASCL1 in Surgically Resected Small Cell Lung Cancer (HOT1702)

Oncologist- United States

doi 10.1634/theoncologist.2018-0676

Full Text

Abstract

Available in

Date

Authors

Publisher

Alphamed Press

Related search

Clinical Outcomes of Surgically Resected Combined Small Cell Lung Cancer: A Two-Institutional Experience

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2017English

A Surgically Resected Case of Small Sized Peripheral Small Cell Lung Cancer With Longitudinal and Subepithelial Growth.

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
1997English

Flot-2 Expression Correlates With EGFR Levels and Poor Prognosis in Surgically Resected Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2015English

Prevalence of DLL3, CTLA-4 and MSTN Expression in Patients With Small Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

P95HER2 Truncated Form in Resected Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

P045 Prognostic Value of MHC-I, PD-L1 and CD8+ TILs Expressions in Patients With Surgically Resected Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

MA09.10 Molecular Profiling and PD-L1 Status in 900 Cases of Surgically Resected Non-Small Cell Lung Cancer With Clinical and Pathological Correlation

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.04-04 Prognostic Value of MHC-I, PD-L1 and CD8+ TILs Expressions in Patients With Surgically Resected Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Oncologic Treatment of Non-Small Cell Lung Cancer Part B: Adjuvant Chemotherapy for Resected Non-Small Cell Lung Carcinoma

2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy